Eupressyl and Pemphigoid - a phase IV clinical study of FDA data

Summary:

Pemphigoid is reported as a side effect among people who take Eupressyl (urapidil), especially for people who are female, 60+ old, also take Amlodipine, and have High blood pressure.

The phase IV clinical study analyzes which people have Pemphigoid when taking Eupressyl. It is created by eHealthMe based on reports of 2,821 people who have side effects when taking Eupressyl from the FDA, and is updated regularly.

What is Eupressyl?

Eupressyl has active ingredients of urapidil. eHealthMe is studying from 2,825 Eupressyl users. Check the latest studies of Eupressyl.

What is Pemphigoid?

Pemphigoid (tense blisters on the skin) is found to be associated with 433 drugs and 531 conditions by eHealthMe. Check the latest studies of Pemphigoid.

On Jul, 19, 2026

2,821 people reported to have side effects when taking Eupressyl.
Among them, 23 people (0.82%) have Pemphigoid.

Among these 23 people:

What is the gender of people who have Pemphigoid when taking Eupressyl? *

female: 77.27 %
male: 22.73 %

What is the age of people who have Pemphigoid when taking Eupressyl? *

What are other drugs people take besides Eupressyl? *

What are other side effects people have besides Pemphigoid? *

Itching: 4 people, 17.39%
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 4 people, 17.39%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 13.04%
Rashes (redness): 3 people, 13.04%
Skin Plaque (red, scaly patches to appear on the skin): 3 people, 13.04%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 2 people, 8.70%
Dermatosis (a disease of the skin, esp. one that does not cause inflammation): 2 people, 8.70%
Concomitant Disease Aggravated (advanced due to some of accompanying): 1 person, 4.35%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 4.35%
Disease Recurrence: 1 person, 4.35%

What are the existing conditions these people have? *

High Blood Pressure: 14 people, 60.87%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 13 people, 56.52%
Type 2 Diabetes: 12 people, 52.17%
Sleep Disorder: 11 people, 47.83%
Dyslipidaemia (abnormal amount of lipids): 11 people, 47.83%
Neuralgia (pain in one or more nerves): 11 people, 47.83%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 9 people, 39.13%
Cardiomyopathy (weakening of the heart muscle): 2 people, 8.70%
Constipation: 2 people, 8.70%
Diabetes: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Eupressyl and have Pemphigoid?

- Check whether Pemphigoid is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eupressyl:

Eupressyl (2,825 reports)

Pemphigoid treatments and more:

Pemphigoid (10,725 reports)

Browse all side effects of Eupressyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pemphigoid:

Pemphigoid (433 drugs)

Browse all the conditions that are associated with Pemphigoid:

Pemphigoid (531 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on urapidil (the active ingredients of Eupressyl) and Eupressyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.